Navigation Links
Rabbit Anti-UBC13 Polyclonal Antibody, Unconjugated from ProSci, Inc
...
...
...
... High Resolution - Efficiently ... 50 to 1000 bp. ... sizing PCR fragments, small ... restriction enzyme digestion, and ...
Biology Products:
(Date:7/30/2014)... the first high-resolution map of the carbon stocks ... Per. The new and improved methodology used to ... future market-based carbon economies. The new carbon ... and it provides the critical input to studies ... use, and enforcement purposes. The technique includes the ...
(Date:7/30/2014)... in the journal Scientific Reports , published by ... Ganguly found that while global temperature is indeed increasing, ... instance, while each year,s average hottest and coldest temperatures ... fall within a wider range of potential high and ... means that even as overall temperatures rise, we may ...
(Date:7/29/2014)... by academics in the University of Bristol,s Nutrition and ... liquid calories into account when planning meals. , The ... Study of Ingestive Behavior Conference (SSIB 2014) in Seattle, ... that we do. , The team was led by ... of Experimental Psychology. , As part of a Biotechnology ...
Breaking Biology News(10 mins):Peru's carbon quantified: Economic and conservation boon 2Peru's carbon quantified: Economic and conservation boon 3Big data confirms climate extremes are here to stay 2
... Fusarium samples. A Virginia Tech plant pathologist ... detect airborne pathogens above agricultural fields. , ... and weed science in the College of Agriculture ... and engineering with his interdisciplinary research but has ...
... common practice among many college students involves "pulling all-nighters", ... practice associated with lower grade-point averages compared to those ... abstract that will be presented Wednesday at SLEEP 2007, ... Societies (APSS). , "Sleep in college students is generally ...
... a microbial protein to improve water quality. , But ... from potentially toxic nanoparticles in their own environments, and ... the same thing on a larger scale. , ... and Lawrence Berkeley National Laboratory found that bacteria from ...
Cached Biology News:Small, self-controlled planes combine plant pathology and engineering 2Small, self-controlled planes combine plant pathology and engineering 3Microbes at work cleaning up the environment 2
(Date:7/30/2014)... July 30, 2014   Epic Sciences, Inc. ... novel diagnostics to personalize and advance the treatment and ... Gregory T. Lucier as chairman of Epic,s board ... of Life Technologies (formerly Invitrogen). Mr. Lucier joins Epic,s ... its circulating rare cell analysis platform with special focus ...
(Date:7/30/2014)... Calif. , July 30, 2014  AtheroNova ... the research and development of compounds to safely ... humans, today announces that its partner, CardioNova, has ... 1b clinical trial with AtheroNova,s lead compound, AHRO-001.  ... of the AHRO-001 Phase 1 safety trial completed ...
(Date:7/30/2014)... , July 30, 2014  RXi ... a biotechnology company focused on discovering, developing ... medical needs using RNA-targeted technologies, today announced ... with RXI-109, for the reduction of recurrence ... surgery, has been initiated. Logo ...
(Date:7/30/2014)... July 30, 2014 NCERC at ... will present his findings on corn stover pretreatment ... this week in Washington, D.C. , “Arun’s ... conference is a testament to the success of ... said. “Thanks to the foresight and vision of ...
Breaking Biology Technology:Epic Sciences Appoints Greg Lucier as Chairman of the Board of Directors 2Epic Sciences Appoints Greg Lucier as Chairman of the Board of Directors 3AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 2AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 3AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 4RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 2RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 3RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 4RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 5NCERC at SIUE Researcher Takes Stage at Department of Energy Conference 2NCERC at SIUE Researcher Takes Stage at Department of Energy Conference 3